After a decade of intravesical vanilloid therapy: still more questions than answers
- 1 July 2002
- journal article
- review article
- Published by Elsevier in The Lancet Neurology
- Vol. 1 (3) , 167-172
- https://doi.org/10.1016/s1474-4422(02)00072-8
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Clinical Applications of CapsaicinoidsThe Clinical Journal of Pain, 2000
- Intravesical treatment of overactive bladderUrology, 2000
- Intravesical Neuromodulatory Drugs: Capsaicin and Resiniferatoxin to Treat the Overactive BladderJournal of Endourology, 2000
- Novel natural vanilloid receptor agonists: new therapeutic targets for drug developmentTrends in Pharmacological Sciences, 1999
- INTRAVESICAL CAPSAICIN AND RESINIFERATOXIN THERAPY: SPICING UP THE WAYS TO TREAT THE OVERACTIVE BLADDERJournal of Urology, 1999
- Desensitization of bladder sensory fibers by intravesical capsaicin or capsaicin analogs. A new strategy for treatment of urge incontinence in patients with spinal detrusor hyperreflexia or bladder hypersensitivity disordersInternational Urogynecology Journal, 1998
- Euphorbium: Modern research on its active principle, resiniferatoxin, revives an ancient medicinePublished by Elsevier ,1998
- The capsaicin receptor: a heat-activated ion channel in the pain pathwayNature, 1997
- Suppression of bladder hyperreflexia by intravesical resiniferatoxinThe Lancet, 1997
- Capsaicin and pain mechanismsBritish Journal of Anaesthesia, 1995